263 related articles for article (PubMed ID: 22922341)
21. Adipose tissue-targeted 11β-hydroxysteroid dehydrogenase type 1 inhibitor protects against diet-induced obesity.
Liu J; Wang L; Zhang A; Di W; Zhang X; Wu L; Yu J; Zha J; Lv S; Cheng P; Hu M; Li Y; Qi H; Ding G; Zhong Y
Endocr J; 2011; 58(3):199-209. PubMed ID: 21325744
[TBL] [Abstract][Full Text] [Related]
22. 11β-HSD1 reduces metabolic efficacy and adiponectin synthesis in hypertrophic adipocytes.
Koh EH; Kim AR; Kim H; Kim JH; Park HS; Ko MS; Kim MO; Kim HJ; Kim BJ; Yoo HJ; Kim SJ; Oh JS; Woo CY; Jang JE; Leem J; Cho MH; Lee KU
J Endocrinol; 2015 Jun; 225(3):147-58. PubMed ID: 25869616
[TBL] [Abstract][Full Text] [Related]
23. Glycine enhances expression of adiponectin and IL-10 in 3T3-L1 adipocytes without affecting adipogenesis and lipolysis.
Chen J; Ma X; Yang Y; Dai Z; Wu Z; Wu G
Amino Acids; 2018 May; 50(5):629-640. PubMed ID: 29356901
[TBL] [Abstract][Full Text] [Related]
24. Growth hormone (GH) or insulin-like growth factor (IGF)-I represses 11beta-hydroxysteroid dehydrogenase type 1 (HSD1) mRNA expression in 3T3-L1 cells and its activity in their homogenates.
Morita J; Hakuno F; Hizuka N; Takahashi S; Takano K
Endocr J; 2009; 56(4):561-70. PubMed ID: 19352050
[TBL] [Abstract][Full Text] [Related]
25. Dehydroepiandrosterone inhibits the amplification of glucocorticoid action in adipose tissue.
Apostolova G; Schweizer RA; Balazs Z; Kostadinova RM; Odermatt A
Am J Physiol Endocrinol Metab; 2005 May; 288(5):E957-64. PubMed ID: 15613680
[TBL] [Abstract][Full Text] [Related]
26. Identification of a novel 11β-HSD1 inhibitor from a high-throughput screen of natural product extracts.
Park SB; Park JS; Jung WH; Park A; Jo SR; Kim HY; Dal Rhee S; Ryu SY; Jeong HG; Park S; Lee H; Kim KY
Pharmacol Res; 2015 Dec; 102():245-53. PubMed ID: 26515507
[TBL] [Abstract][Full Text] [Related]
27. Genistein inhibits glucocorticoid amplification in adipose tissue by suppression of 11β-hydroxysteroid dehydrogenase type 1.
Tagawa N; Kubota S; Kobayashi Y; Kato I
Steroids; 2015 Jan; 93():77-86. PubMed ID: 25447798
[TBL] [Abstract][Full Text] [Related]
28. 11beta-Hydroxysteroid dehydrogenase type 1 regulates insulin and glucagon secretion in pancreatic islets.
Swali A; Walker EA; Lavery GG; Tomlinson JW; Stewart PM
Diabetologia; 2008 Nov; 51(11):2003-11. PubMed ID: 18779947
[TBL] [Abstract][Full Text] [Related]
29. BVT.2733, a selective 11β-hydroxysteroid dehydrogenase type 1 inhibitor, attenuates obesity and inflammation in diet-induced obese mice.
Wang L; Liu J; Zhang A; Cheng P; Zhang X; Lv S; Wu L; Yu J; Di W; Zha J; Kong X; Qi H; Zhong Y; Ding G
PLoS One; 2012; 7(7):e40056. PubMed ID: 22768329
[TBL] [Abstract][Full Text] [Related]
30. Inhibition of 11β-HSD1 by LG13 improves glucose metabolism in type 2 diabetic mice.
Zhao L; Pan Y; Peng K; Wang Z; Li J; Li D; Tong C; Wang Y; Liang G
J Mol Endocrinol; 2015 Oct; 55(2):119-31. PubMed ID: 26220348
[TBL] [Abstract][Full Text] [Related]
31. Tissue-specific glucocorticoid reactivating enzyme, 11 beta-hydroxysteroid dehydrogenase type 1 (11 beta-HSD1)--a promising drug target for the treatment of metabolic syndrome.
Masuzaki H; Flier JS
Curr Drug Targets Immune Endocr Metabol Disord; 2003 Dec; 3(4):255-62. PubMed ID: 14683456
[TBL] [Abstract][Full Text] [Related]
32. Effect of high-fat diet on KKAy and ob/ob mouse liver and adipose tissue corticosterone and 11-dehydrocorticosterone concentrations.
Alberts P; Rönquist-Nii Y; Larsson C; Klingström G; Engblom L; Edling N; Lidell V; Berg I; Edlund PO; Ashkzari M; Sahaf N; Norling S; Berggren V; Bergdahl K; Forsgren M; Abrahmsén L
Horm Metab Res; 2005 Jul; 37(7):402-7. PubMed ID: 16034710
[TBL] [Abstract][Full Text] [Related]
33. Korean Chungtaejeon tea extract attenuates body weight gain in C57BL/6J-Lep ob/ob mice and regulates adipogenesis and lipolysis in 3T3-L1 adipocytes.
Sharma BR; Kim DW; Rhyu DY
J Integr Med; 2017 Jan; 15(1):56-63. PubMed ID: 28088260
[TBL] [Abstract][Full Text] [Related]
34. Benzofuran derivatives inhibit 11β-hydroxysteroid dehydrogenase type 1 activity in rat adipose tissue.
Kiyonaga D; Tagawa N; Yamaguchi Y; Wakabayashi M; Kogure T; Ueda M; Miyata O; Kobayashi Y
Biol Pharm Bull; 2012; 35(8):1275-80. PubMed ID: 22863925
[TBL] [Abstract][Full Text] [Related]
35. Leptin activation of corticosterone production in hepatocytes may contribute to the reversal of obesity and hyperglycemia in leptin-deficient ob/ob mice.
Liu Y; Nakagawa Y; Wang Y; Li R; Li X; Ohzeki T; Friedman TC
Diabetes; 2003 Jun; 52(6):1409-16. PubMed ID: 12765951
[TBL] [Abstract][Full Text] [Related]
36. 11β-Hydroxysteroid dehydrogenase type 1 selective inhibitor BVT.2733 protects osteoblasts against endogenous glucocorticoid induced dysfunction.
Wu L; Qi H; Zhong Y; Lv S; Yu J; Liu J; Wang L; Bi J; Kong X; Di W; Zha J; Liu F; Ding G
Endocr J; 2013; 60(9):1047-58. PubMed ID: 23759754
[TBL] [Abstract][Full Text] [Related]
37. Dehydroepiandrosterone exerts antiglucocorticoid action on human preadipocyte proliferation, differentiation, and glucose uptake.
McNelis JC; Manolopoulos KN; Gathercole LL; Bujalska IJ; Stewart PM; Tomlinson JW; Arlt W
Am J Physiol Endocrinol Metab; 2013 Nov; 305(9):E1134-44. PubMed ID: 24022868
[TBL] [Abstract][Full Text] [Related]
38. 11beta-hydroxysteroid dehydrogenase type 1 and obesity.
Morton NM; Seckl JR
Front Horm Res; 2008; 36():146-164. PubMed ID: 18230901
[TBL] [Abstract][Full Text] [Related]
39. 4-(Phenylsulfonamidomethyl)benzamides as potent and selective inhibitors of the 11beta-hydroxysteroid dehydrogenase type 1 with efficacy in diabetic ob/ob mice.
Zhang X; Zhou Z; Yang H; Chen J; Feng Y; Du L; Leng Y; Shen J
Bioorg Med Chem Lett; 2009 Aug; 19(15):4455-8. PubMed ID: 19564108
[TBL] [Abstract][Full Text] [Related]
40. Inhibition of 11β-hydroxysteroid dehydrogenase 1 by carbenoxolone affects glucose homeostasis and obesity in db/db mice.
Dhanesha N; Joharapurkar A; Shah G; Kshirsagar S; Dhote V; Sharma A; Jain M
Clin Exp Pharmacol Physiol; 2012 Jan; 39(1):69-77. PubMed ID: 22060140
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
